Thirty-one molecules, none of them already yours.

Atenolol

Demand of 87 on a molecule prescribers already know and reach for by habit. This is the volume line that carries the container: it fills shipments, holds the manufacturer relationship steady, and lets the thinner specialty lines travel alongside it profitably.

Metoprolol

Extended-release formulation capability narrows the credible manufacturer field well beyond what seven registrations suggests, so the real competitive set is smaller than the number implies. We confirm ER capability at shortlist stage rather than at RFQ.

Enalapril

Standard first-line ACE inhibitor for hypertension and heart failure, and it sits on the same manufacturers as Amlodipine. Sourcing the pair together is where the consolidation saving shows up on the invoice.

Methyldopa

Drug of choice for hypertension in pregnancy, a guideline-locked indication that newer agents have not displaced and are unlikely to. Three registrations against demand of 79 makes this one of the cleanest openings in the portfolio.

Hydralazine

Required stock wherever obstetric care is delivered, for severe hypertension and hypertensive emergency in pregnancy. Three registrations for an injectable with no real substitute in its indication, which is about as protected as a generic position gets.

Propranolol

Unusually broad indication set — hypertension, angina, arrhythmia, migraine prophylaxis, thyrotoxicosis, essential tremor — so demand is spread across several prescriber groups and resilient to any single guideline change. Two registrations against that breadth.

Rosuvastatin + Ezetimibe

No registrations for the fixed-dose combination anywhere in Tanzania. Dual lipid-lowering therapy is standard practice where statin monotherapy misses target, so this is an unserved line rather than a slow one — first mover takes the category.

Oxytocin

First-line for postpartum haemorrhage and mandatory stock in every facility that delivers babies, so demand is structural rather than seasonal. Cold chain handling is where a vetted manufacturer earns its premium here.

Misoprostol

The uterotonic of choice wherever cold chain cannot be guaranteed, which describes most of the territory. Demand of 85 is the highest in this category.

Medroxyprogesterone

You held three registrations for this with Eugia Pharma and all three have lapsed. Long-acting injectable contraception moves very large donor- and government-funded volumes on published, scheduled cycles. Reinstating a position you already know how to sell is faster than opening a new one.

Carbetocin

The heat-stable alternative to Oxytocin, developed for exactly the cold-chain conditions in this market. Two registrations against a gap score of 81: the narrowest supplier field in the portfolio and the strongest margin structure with it.

Chlorpromazine

The workhorse antipsychotic across public mental health services, where newer agents stay out of budget for the foreseeable future. Demand of 83 against five registrations is a favourable ratio for a molecule this widely used.

Amitriptyline

Volume now comes as much from neuropathic pain and migraine prophylaxis as from depression, which broadens the prescriber base well beyond the psychiatry channel and makes demand steadier than the category label suggests.

Haloperidol

One of very few injectable antipsychotics on public formularies and essential for acute presentation. The injection is what carries the institutional relationship, and only three suppliers hold it.

Flucloxacillin

First-line for staphylococcal skin and soft-tissue infection, with steady pull from both retail and hospital channels. Two registrations against consistent, year-round prescribing volume.

Fosfomycin trometamol

Single-dose oral therapy for uncomplicated UTI: one sachet, one course, near-perfect compliance. A genuine convenience advantage over multi-day regimens, held by one registration.

Colistimethate sodium

Last-line therapy for multi-drug-resistant Gram-negative infection. Low volume by nature and entirely unsubstitutable when it is needed, which is exactly the combination that supports specialty pricing.

Ivermectin

Highest score in the portfolio. There are 53 active Ivermectin registrations in Tanzania and every one of them is veterinary — not a single human-medicine registration exists. Against the onchocerciasis, strongyloidiasis and scabies burden in this market, that is the widest open position on the list.

Praziquantel

The only drug for schistosomiasis, which is endemic across Tanzania and moves in nationally programmed mass drug administration campaigns. Demand of 86 against four registrations, on a calendar you can plan production around.

Albendazole

Highest demand score in the portfolio at 88. Deworming campaigns move very large volumes in concentrated windows, and the paediatric suspension is the presentation those campaigns actually require.

Budesonide + Formoterol

The maintenance combination that asthma guidelines now build around, replacing reliever-only treatment. Device manufacturing requirements keep the credible supplier field small and the pricing firm.

Ipratropium + Salbutamol

Standard nebulised therapy for acute exacerbation in emergency and inpatient settings — a hospital staple held by a single registration.

Tiotropium

Long-acting maintenance therapy for COPD, a burden growing steadily across the market. The dry-powder capsule format again restricts who can credibly manufacture it, which protects the position once held.

Alendronate

First-line osteoporosis therapy on a once-weekly schedule that drives long-term adherence and predictable repeat purchase. One registration in a market with an ageing population and rising diagnosis rates.

Denosumab

Biologic osteoporosis therapy for patients who cannot tolerate or have failed bisphosphonates. High value per unit, cold chain required, one registration — the most defensible specialty position in the portfolio.

Norepinephrine

First-line vasopressor for septic shock and the backbone of any functioning intensive care unit. Zero registrations in Tanzania against expanding critical care capacity: a structural opening, not a competitive one.

Atropine

Required on every anaesthesia and resuscitation trolley, so it is effectively non-optional stock for any facility with a theatre. One registration, and it travels naturally with the rest of the injectable basket.

Hydrocortisone

Your existing hydrocortisone registration is the clotrimazole combination cream, which does not substitute for this. Oral replacement therapy for adrenal insufficiency, where patients are dose-dependent for life — demand does not churn. No registrations exist for the tablet presentation; the ones on the register are creams and injections, which do not substitute.

Ofloxacin

Topical therapy for otitis externa and chronic suppurative otitis media, both high-prevalence and routinely undertreated here. One registration for the ear presentation specifically.

Rifaximin

Non-absorbed antibiotic for hepatic encephalopathy and travellers' diarrhoea. No registrations at all in Tanzania and no direct substitute for the hepatic indication — gap score of 91, the second highest in the portfolio.

Calcium carbonate

High-turnover retail line with genuine pharmacy pull-through. Its job here is shipment economics: it keeps container volumes efficient so the low-volume specialty injectables above travel at sensible cost.